NCT00006081View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

June 30, 2000

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Esophageal CancerGastric Cancer
Interventions
DRUG

Bryostatin-1

40 mcg/m2 one-hour infusion 24 hours after each dose of paclitaxel (i.e., day 2, 9, 16).

DRUG

Paclitaxel (Taxol)

80 mg/m\^2 one-hour infusion weekly x 3 every 4 weeks

Trial Locations (2)

77030-4009

CCOP - M.D. Anderson Research Base, Houston

University of Texas - MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER